open access
Post-treatment surveillance in most common solid malignancies in adults
open access
Abstract
Surveillance after oncological treatment constitutes a necessary element of comprehensive cancer care. Determining optimal follow-up schedules, including their cost effectiveness, is critical on clinical, organisational and economic grounds. Owing to a lack of prospective clinical studies providing the highest level of evidence, in most cancers optimal surveillance schemes cannot be determined. Hence, currently most recommendations are based on retrospective studies and expert opinions. In Poland comprehensive and uniform recommendations on post-treatment surveillance in cancer patients are not available. This article, prepared by a group of experts in oncology and family medicine, presents a proposal for the follow-up schemes after treatment in major solid malignancies in adults.
Abstract
Surveillance after oncological treatment constitutes a necessary element of comprehensive cancer care. Determining optimal follow-up schedules, including their cost effectiveness, is critical on clinical, organisational and economic grounds. Owing to a lack of prospective clinical studies providing the highest level of evidence, in most cancers optimal surveillance schemes cannot be determined. Hence, currently most recommendations are based on retrospective studies and expert opinions. In Poland comprehensive and uniform recommendations on post-treatment surveillance in cancer patients are not available. This article, prepared by a group of experts in oncology and family medicine, presents a proposal for the follow-up schemes after treatment in major solid malignancies in adults.
Keywords
malignant diseases, post-treatment surveillance, recommendations
About this articleTitle
Post-treatment surveillance in most common solid malignancies in adults
Journal
Issue
Article type
Guidelines / Expert consensus
Pages
290-313
Published online
2015-01-07
Page views
743
Article views/downloads
5912
Bibliographic record
Onkol. Prak. Klin 2014;10(6):290-313.
Keywords
malignant diseases
post-treatment surveillance
recommendations
Authors
Jacek Jassem
Renata Duchnowska
Andrzej Kawecki
Romuald Krajewski
Maciej Krzakowski
Radosław Mądry
Piotr Potemski
Piotr Rutkowski
Janusz Siebert
Adam Windak
Piotr Wysocki